Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 94Neoplasm Metastasis 6Breast Diseases 3Prostatic Neoplasms 2Ovarian Neoplasms 2Endometrial Neoplasms 2Breast Cancer Metastatic 2Triple Negative Breast Neoplasms 1Recurrence 1Primary Breast Cancer ER+ve 1Pancreatic Neoplasms 1Neoplasms 1Neoadjuvant Treatment for HER2-positive, ER-positive Breast Cancer 1Multiple Endocrine Neoplasia Type 1 1Metastatic Beast Cancer 1Mammary Neoplasms, Animal 1Locoregional Recurrence 1Lethal Congenital Contracture Syndrome 2 1Hyperglycemia 1Hormone Receptor Positive Malignant Neoplasm of Breast 1HER2-positive Breast Cancer 1Granulosa cell tumor of the ovary 1Estrogen-receptor Positive Invasive Metastatic Breast Cancer 1Endometrial Stromal Tumors 1Endometrial Hyperplasia 1ER+ Breast Cancer 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Intraductal, Noninfiltrating 1Carcinoma, Ductal 1Bulbo-Spinal Atrophy, X-Linked 1

Interventions

Specimen Handling 2Magnetic Resonance Spectroscopy 2olaparib 1exemestane 1abemaciclib 1X-Rays 1Tamoxifen 1Letrozole 1Gonadotropin-Releasing Hormone 1Fulvestrant 1Fluorodeoxyglucose F18 1Estradiol 1Biopsy 1Anastrozole 1Alpelisib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Anatomic Stage III Breast Cancer AJCC v8 × exemestane × Clear all
NCT06179303 2026-04-16

Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer

University of Washington

Phase 2 Recruiting
60 enrolled
Breast

Anatomic Stage III Breast Cancer AJCC v8

Data powered by HemOnc (CC BY 4.0) Colophon âš¡